Monday, May 21, 2018
 
 
Company News: Page (1) of 1 - 02/13/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Congress Validates MIPS Program and Supports Risk-Based ACOs

(February 13, 2018)

KANSAS CITY, Mo., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Caravan Health today commented on the approval of the Bipartisan Budget Act of 2018. The two-year budget bill – approved by the U.S. Congress on Friday – includes minor amendments to the Centers for Medicare & Medicaid Services’ (CMS) Merit-Based Incentive Payment System (MIPS). The most notable change requires CMS to “increase the performance threshold…to ensure a gradual and incremental transition to the performance threshold” required by the mean/median calculation in the sixth year of the program (performance year 2022). 


The legislation modestly decreases the impact of MIPS on providers, and demonstrates continued preference for hospitals and providers participating in risk-bearing payment models such as track 1+, 2, and 3 of the Medicare Shared Savings Program. Despite thes changes, Caravan Health – who currently serves 38 Accountable Care Organizations (ACOs) – notes recent rumors that Congress would repeal MIPS have not come to pass and that Congress has again, supported the long-term structure of the MIPS program. 

“Congress is sending a strong signal to providers that value-based payments, MIPS and ACOs are here to stay,” said Lynn Barr, Caravan Health chief executive officer. “Our ACO-partner results show that participating in an ACO now will best prepare providers to enter into a risk-bearing model in the future.” 

The MIPS provisions will allow risk-bearing ACOs to offer incentives to promote in-ACO care and enable participants to provide telehealth services to patients in their homes. Combined, the incentives add to the appeal of the MIPS 5 percent bonus, available only to risk-bearing models.  

More information regarding the impact of the budget bill for ACOs can be read at https://caravanhealth.com/federal-budget-mips-risk-based-payment-models-medicare/. Caravan Health provides ongoing guidance to health care systems transitioning to value-based payments and will continue to monitor and evaluate policy changes.  

About Caravan Health:
Caravan Health builds ACOs that jump-start population health programs with immediate quality and financial wins. Hospitals can finally get the high-quality scores, new competencies, and strong physician relationships that have been out of reach. By quickly producing positive results and accelerating health care transformation, Caravan Health engineers hospitals to succeed in population health payment models. For more information, visit caravanhealth.com.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e502f763-f605-462d-a0c5-99c562ecee9a



CONTACT: Sage BeardCaravan [email protected]

Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
  • Regenerative Medicine Market Analysis Study Found Huge Boom By Rising Prevalence Of Chronic Diseases And Genetic Disorders Till 2025: Grand View Research,Inc.
  • Global Molecular Diagnostics Markets, 2016-2024 - Focus on Infectious Disease Testing, Blood Screening, Cancer Screening & Other Applications
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Strategic Business Report 2018
  • Global Sleep Apnea Diagnostic and Therapeutic Devices: 2016/18-2024 Strategic Business Analysis & Forecast Report - mHealth-Enabled Sleep Tracking Devices Gain Ground

    Cancer
  • Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
  • Altogen Labs xenograft services for drug development studies of anti-cancer therapeutics
  • HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
  • Dr. Haydee Gonzalez Hidalgo joins The Oncology Institute of Hope and Innovation
  • eClinical Solutions Market Size Is Projected To Reach $13 Billion By 2024
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines